Centerline Biomedical Inc. of Cleveland announced it has launched the first clinical study of its Intra-Operative Positioning System (IOPS) surgical navigation platform, a key step in gaining entry to international markets.
In a news release, Centerline said the IOPS technology, which has been cleared by the U.S. Food and Drug Administration, is “being deployed in a controlled launch at Cleveland Clinic and other leading institutions in the United States.”
Click here to read the complete story.
Story excerpt provided by Crain’s Cleveland Business.
Written by Scott Suttell.
Originally published December 16, 2020.